Most people who consider these medications have already tried. They have counted, restricted, restarted, and lost ground again, and by the time they book a consultation, they are usually wondering whether the problem is discipline. It generally is not. Appetite is regulated by hormonal signaling, and for some people those signals work against every plan they make.
Semaglutide and tirzepatide work on that signaling directly. At My Wellness Studio in Leesburg, FL, they are prescribed as part of a medical weight loss program rather than on their own, with your health history reviewed first, your dose adjusted as you respond, and support in place for what happens when the medication stops.
Both are injectable prescription medications used in medically supervised weight management, and both work by mimicking hormones your body already produces to regulate appetite and blood sugar. They are given as a weekly injection, and dosing starts low and increases gradually.
Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone released after eating that signals fullness to the brain, slows how quickly the stomach empties, and influences insulin release. Semaglutide mimics that hormone, which is why many patients describe feeling satisfied sooner and thinking about food far less.
Tirzepatide acts on two receptors rather than one: GLP-1 and GIP. GIP is a second gut hormone involved in how the body handles nutrients and stores fat. Acting on both pathways gives tirzepatide a different mechanism, and some patients respond better to it than to GLP-1 alone.
Which one suits you is a clinical decision rather than a preference. Your health history, other medications, how you tolerate the first doses, and your insurance coverage all factor into it, and your provider will explain the reasoning behind the recommendation.
The effect people notice first is usually the quiet. Constant background thinking about food, sometimes called food noise, tends to reduce, and that is the mechanism rather than a side effect. These medications act on appetite regulation in the brain, so eating less stops requiring the same effort it did before.
Alongside that, both medications slow gastric emptying, so food stays in the stomach longer and fullness lasts. Both also influence insulin release in response to eating, which affects how steadily blood sugar moves through the day. Tirzepatide adds the GIP pathway to that picture, which is the difference between the two.
What neither medication does is work independently of everything else. Protein intake, resistance training, and sleep all affect what happens to your body composition while you are on treatment, which is why this is prescribed inside a program rather than as a standalone prescription.
Semaglutide and tirzepatide work systemically rather than on specific areas of the body. They do not target fat in one region, and no injectable medication produces spot reduction. What they influence is the physiology underneath:
Patients in Leesburg, FL, come to us for these medications for reasons that usually overlap:
You may be a candidate if you have struggled to manage your weight through diet and exercise alone, have regained weight after previous attempts, or want clinical oversight rather than another self-directed plan. Candidacy is determined by your provider after reviewing your health history rather than by preference, and it is decided at consultation rather than online.
These medications are not appropriate for everyone. They are not prescribed during pregnancy or breastfeeding, or for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. A history of pancreatitis, gallbladder disease, severe gastrointestinal disease, or diabetic retinopathy all require careful evaluation before treatment is considered.
Tell your provider about every medication and supplement you take, including anything over the counter. If treatment is not appropriate for you, the non-pharmaceutical side of our weight loss and wellness program is still available, and you will be told directly rather than sold something that will not suit you.
Your first visit is a consultation. Your provider reviews your health history, current medications, previous weight loss attempts and goals, and may order laboratory work depending on what your history shows. A body composition scan establishes your starting point in terms of fat and lean mass rather than weight alone.
If medication is appropriate, you and your provider decide which one and start at a low dose. Doses increase gradually on a planned schedule, because that is how tolerability is managed. You will be shown how to administer the injection, and most patients handle it at home from the first week.
From there, the pattern is check in, review, adjust. Follow-up appointments cover how you are feeling, how the medication is being tolerated, and what is proving difficult, and your dose is adjusted accordingly. Adjustments are normal and expected rather than a sign that anything has gone wrong.
This is the question worth asking before you start rather than at the end. Appetite regulation generally returns toward where it was once the medication stops, and for many people, weight follows. That is not a failure of the treatment; it is how the medication works.
What changes the outcome is what is built alongside it. Nutrition habits, resistance training, sleep and the accountability of regular check-ins are the things that persist when the prescription does not, which is why they are part of the program rather than an afterthought. How long you stay on treatment is a clinical decision reviewed with your provider rather than fixed in advance, and the transition off it is planned well before it happens.
Option | How It Works | How It Is Taken | Best Suited To |
|---|---|---|---|
Semaglutide | GLP-1 receptor agonist affecting appetite signaling | Weekly injection | Patients seeking appetite support under medical supervision |
Tirzepatide | Dual GIP and GLP-1 receptor agonist | Weekly injection | Patients whose provider determines a dual-action option suits them |
Thinnr Program | Structured nutrition and lifestyle guidance with oversight | No medication | Patients starting without medication or not eligible for it |
Biote Hormone Therapy | Pellet-based hormone optimization guided by testing | Pellet insertion | Patients whose weight difficulty is hormonally driven |
EmSculpt NEO | Electromagnetic energy and radiofrequency | In-clinic sessions | Patients addressing muscle and contour rather than overall weight |
These are not alternatives so much as parts of a plan. Which combination suits you is a clinical decision based on your health history and your goals, made at consultation rather than from a page.
My Wellness Studio delivers GLP-1 therapy inside a wider wellness practice rather than as a standalone prescription service, which means the things that determine whether it works long term are available in the same building.
My Wellness Studio proudly offers semaglutide and tirzepatide in Leesburg, FL, welcoming patients from surrounding communities seeking medical weight loss. Our centrally located office allows us to serve clients from:
Semaglutide acts on one receptor, GLP-1. Tirzepatide acts on two receptors, GLP-1 and GIP, which gives it a different mechanism. Neither is automatically better. Which suits you depends on your health history, how you tolerate the first doses, other medications and coverage, and your provider makes that recommendation after your assessment.
Appetite regulation generally returns toward where it was before, and for many people weight follows. That is why the nutrition, movement, and accountability side of the program matters, and why the transition off medication is planned well before it happens rather than left to chance.
Some loss of lean mass alongside fat is common with any significant weight loss, not only with these medications. That is why body composition is scanned rather than only weighed. If your scans show lean mass dropping, your plan is adjusted, usually through protein intake and resistance training.
Losing facial fullness is a real effect of significant fat loss rather than a side effect of the medication itself. Fat is lost throughout the body, including the face, and it is more noticeable when loss happens quickly. Pace, protein, and hydration all help. Where volume has already been lost, treatments that restore it are available here and can be discussed at a follow-up.
They are not prescribed during pregnancy or breastfeeding, or for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. A history of pancreatitis, gallbladder disease, severe gastrointestinal disease, or diabetic retinopathy requires careful evaluation. Your provider reviews all of this at consultation.
No. This is a small subcutaneous injection given with a fine needle, comparable to any routine injection. Most patients describe a brief pinch and nothing after that, and no numbing is needed.
Cost depends on which medication is prescribed, your dose, and how long you continue treatment, so pricing is confirmed at consultation rather than quoted in advance. Coverage varies considerably between insurers, and many plans exclude weight management specifically. Patient financing is available through Cherry and PatientFi.
Both are prescription medications with established benefits and known risks, which is why they are prescribed and monitored rather than sold. Safety is managed through screening before treatment, conservative starting doses, gradual increases, and regular follow-up. Your individual risk is reviewed against your health history before anything is prescribed.
The earliest change most patients notice is appetite, often within the first few weeks. Changes in body composition develop over months and depend on protein intake, activity, and consistency alongside the medication. Individual response varies considerably, which is why progress is measured rather than predicted.
The most common are gastrointestinal: nausea, changes in bowel habit, reflux and reduced appetite beyond what is comfortable. Most are dose-related and settle as your body adjusts or after an adjustment. Less common but more serious effects, including pancreatitis and gallbladder problems, are reviewed with you before treatment and are part of why monitoring matters.
If you have tried before and it has not held, a medically supervised program built around measurement rather than willpower is a different proposition. Your provider will review your history, establish where you are actually starting from, and tell you honestly whether these medications are the right fit. Visit us at 920 E Dixie Ave, Leesburg, FL 34748, call (352) 728-0786, or get in touch to book.
